H, K., M, S., & K, Y. (2021). Development of Rheumatoid Arthritis During Anti-Interleukin-5 Therapy in a Patient with Refractory Chronic Eosinophilic Pneumonia. Dove Medical Press.
Cita Chicago Style (17a ed.)H, Kawabata, Satoh M, y Yatera K. Development of Rheumatoid Arthritis During Anti-Interleukin-5 Therapy in a Patient with Refractory Chronic Eosinophilic Pneumonia. Dove Medical Press, 2021.
Cita MLA (8a ed.)H, Kawabata, et al. Development of Rheumatoid Arthritis During Anti-Interleukin-5 Therapy in a Patient with Refractory Chronic Eosinophilic Pneumonia. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.